The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.  
               April 2023   in “Journal of Investigative Dermatology”    cp-asiAR may effectively treat hair loss by targeting androgen receptors.  
               November 2022   in “Molecular Pharmaceutics”    cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.  
     
           June 2025   in “Current Issues in Molecular Biology”    Meloside A may help protect hair cells from damage linked to hair loss.  
               August 2024   in “Cosmetics”    Personalized treatments for hair loss are becoming more effective by using genetic information.